Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.1050 (5.31%) ($11.1050 - $11.1350) on Mon. Dec. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 38 | Latest Price | $11.1050(5.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(21%) XLK(20%) BLOK(19%) BND(19%) VUG(18%) | Factors Impacting BCRX price | BCRX will decline at least -1.895% in a week (0% probabilities). SMH(-26%) ARKG(-17%) VIXM(-10%) SHY(-6%) GLD(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.43(-130.89%) | Resistance Level | $12.14 | 5 Day Moving Average | $10.74(3.4%) | 10 Day Moving Average | $11.65(-4.68%) | 20 Day Moving Average | $12.14(-8.53%) | To recent high | -21.9% | To recent low | 6.1% | Market Cap | $1.959b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |